IP Library Granted Patent US 9,758,823
Granted Patent B2
US 9,758,823 · App. 14/351,038 · Granted Sep 12, 2017

Enzyme method

Inventors: Ruth Moysey (Oxford, GB); Andrew John Heron (Oxford, GB)
Assignee: Oxford Nanopore Technologies Limited
C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,758,823
App. No.
14/351,038
Granted
Sep 12, 2017
Kind
B2
Abstract

The invention relates to a new method of characterizing a target polynucleotide. The method uses a pore and a Hel308 helicase or amolecular motor which is capable of binding to the target polynucleotide at an internal nucleotide. The helicase or molecular motor controls the movement of the target polynucleotide through the pore.

Claims (14)

1. A method of characterising a target polynucleotide, comprising:

(a) providing in an aqueous solution a transmembrane pore and a membrane, wherein the transmembrane pore is present in the membrane, and wherein the aqueous solution comprises a salt at a concentration in a range of 0.3 M to 3 M;

(b) combining, in the aqueous solution of step (a), the target polynucleotide and a Hel308 helicase, wherein the helicase binds to the target polynucleotide to form a polynucleotide helicase complex, thereby controlling the movement of the target polynucleotide through the transmembrane pore; and

(c) measuring, during an application of a potential across the transmembrane pore, an ionic current as the target polynucleotide moves through the transmembrane pore, to determine one or more characteristics of the target polynucleotide and thereby characterising the target polynucleotide.

2. A method according to claim 1 , wherein the one or more characteristics are selected from (i) the length of the target polynucleotide, (ii) the identity of the target polynucleotide, (iii) the sequence of the target polynucleotide, (iv) the secondary structure of the target polynucleotide and (v) whether or not the target polynucleotide is modified.

3. A method according to claim 2 , wherein the target polynucleotide is modified by methylation, by oxidation, by damage, with one or more proteins or with one or more labels, tags or spacers.

4. A method according to claim 1 , wherein at least a portion of the polynucleotide is double stranded.

5. A method according to claim 1 , wherein the transmembrane pore is a protein pore.

6. A method according to claim 5 , wherein the transmembrane protein pore is selected from the group consisting of: α-hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP) and WZA.

7. A method according to claim 1 , wherein the Hel308 helicase comprises the amino acid motif Q-X1-X2 G R A G R (SEQ ID NO: 8), wherein X1 is C, M or L and X2 is any amino acid residue.

8. A method according to claim 7 , wherein X2 is A, F, M, C, V, L, I, S, T or P.

9. A method according to claim 1 , wherein the Hel308 helicase is capable of binding to the target polynucleotide at an internal nucleotide.

10. A method according to claim 1 , wherein the salt is KCl.

11. A method according to claim 10 , wherein the salt concentration is at least 1.0 M.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2014
From: MOYSEY, RUTH; HERON, ANDREW JOHN
To: OXFORD NANOPORE TECHNOLOGIES LIMITED
Reel/Frame 033555/0917 →
Continuity (3)
Provisional Application 61599244 · Feb 15, 2012
Provisional Application 61549998 · Oct 21, 2011
Related Publication 20140255921A1 · Sep 11, 2014